Position in APGE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,650,038
+$6,396,743 QoQ
Shares Held
50,102
+678.3% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#105
of 281 holders
Holding Since
Jun 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Centiva Capital, LP holds $32,694,585 across 26 Biotechnology names. APGE ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
225,000 | $15,896,250 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
This page
|
50,102 | $6,650,038 | |
| 3 | MANE |
Veradermics, Inc
|
25,817 | $3,173,941 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
5,107 | $956,438 | |
| 5 | CYTK |
Cytokinetics Inc
|
9,643 | $821,487 | |
| 6 | IDYA |
IDEAYA Biosciences, Inc.
|
21,800 | $812,486 | |
| 7 | ERAS |
Erasca, Inc.
|
34,251 | $627,478 | |
| 8 | ABVX |
Abivax S.A.
|
4,512 | $601,269 |
All Filings in APGE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,650,038 | 50,102 | Shares | Sole | 2026-08-13 | |
| 2024-06-30 | $253,295 | 6,437 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||